Suarez L, Hendricks K A, Cooper S P, Sweeney A M, Hardy R J, Larsen R D
Texas Department of Health, Austin 78756, USA.
Am J Epidemiol. 2000 Dec 1;152(11):1017-23. doi: 10.1093/aje/152.11.1017.
Populations of Mexican descent have high occurrences of neural tube defects (NTDs). A recent study suggested that folic acid supplements may not protect these populations from NTDs. In a case-control study, the authors investigated the role of folic acid and dietary folate intake in NTD risk among Mexican Americans living along the Texas-Mexico border. From January 1995 to February 1999, 148 Mexican-American women with NTD-affected pregnancies and 158 women with normal live births were interviewed in person about use of vitamin supplements and dietary intakes during a 6-month periconceptional period (from 3 months before conception to 3 months after conception). Daily preconceptional consumption of vitamin supplements containing folic acid was 2.5% in control women and 2.0% in case women (odds ratio = 0.77; 95% confidence interval (CI): 0.19, 3.22). With adjustment for maternal age, education, obesity, and previous stillbirth or miscarriage, the risk estimate was essentially null (odds ratio = 1.12; 95% CI: 0.22, 5.78). Combined folic acid intake from diet and supplements showed only a modest risk reduction for intakes of > or = 1.0 mg per day (adjusted odds ratio = 0.73; 95% CI: 0.31, 1.72). The fact that the primary folic acid exposure was in the form of dietary polyglutamates rather than the more easily absorbed supplemental monoglutamates may explain an apparent decreased effect in this population.
墨西哥裔人群中神经管缺陷(NTDs)的发生率很高。最近一项研究表明,叶酸补充剂可能无法保护这些人群免受神经管缺陷的影响。在一项病例对照研究中,作者调查了叶酸和膳食叶酸摄入量在德克萨斯 - 墨西哥边境的墨西哥裔美国人神经管缺陷风险中的作用。从1995年1月至1999年2月,对148名怀有神经管缺陷胎儿的墨西哥裔美国妇女和158名正常活产妇女进行了面对面访谈,询问她们在受孕前6个月期间(从受孕前3个月到受孕后3个月)维生素补充剂的使用情况和膳食摄入量。对照组妇女孕前每日服用含叶酸的维生素补充剂的比例为2.5%,病例组妇女为2.0%(比值比 = 0.77;95%置信区间(CI):0.19,3.22)。在对产妇年龄、教育程度、肥胖情况以及既往死产或流产情况进行调整后,风险估计基本为零(比值比 = 1.12;95%CI:0.22,5.78)。饮食和补充剂中叶酸的总摄入量仅在每日摄入量≥1.0毫克时显示出适度的风险降低(调整后的比值比 = 0.73;95%CI:0.31,1.72)。主要的叶酸暴露形式是膳食多聚谷氨酸盐而非更容易吸收的补充剂单谷氨酸盐这一事实,可能解释了该人群中明显降低的效果。